News

• 2026.05.22 news
  Announcement of the publication of an interview article in the Science Newspaper
• 2026.05.19 news
  Announcement of Tohoku University’s Press Release on Phase II Clinical Trial Results for Angiosarcoma
• 2026.05.15 news
  Announcement of an Article in Kahoku Shimpo
• 2026.05.15 news
  Announcement Regarding Publication of XPRIZE Healthspan Semi-Final Clinical Trial Results
• 2026.05.15 news
  Announcement of NHK Coverage of Research Related to Our Company
• 2026.05.14 news
  Announcement of an article in the Nihon Keizai Shimbun
• 2026.05.14 news
  Video clip of the results of the XPRIZE Healthspan semi-final clinical trial
• 2026.05.07 news
  Announcement of Publication of a Paper on the Anti-Aging Effects of PAI-1 Inhibitor RS5614: Enhancement of the immune system’s ability to remove “damaged and senescent cells” (efferocytosis).
• 2026.04.09 news
  Collaboration with Tohoku University’s Healthspan Research Center (HeSReC) and Promotion of Industry-Academia Collaboration for Extending Healthy Lifespan
• 2026.03.30 news
  Announcement of Publication of a Paper Delineating the Mechanism of Removal of Aged Cells and Damaged Cells by PAI-1 Inhibitor TM5614